Oligonucleotide compounds for targeting huntingtin mRNA

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9809817
SERIAL NO

15089319

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This disclosure relates to novel huntingtin targets. Novel oligonucleotides for the treatment of Huntington's disease are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF MASSACHUSETTSONE BEACON STREET 31ST FLOOR BOSTON MA 02108

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alterman, Julia Worcester, US 26 446
Aronin, Neil Newtonville, US 47 753
Khvorova, Anastasia Westborough, US 393 10160

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 7, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 7, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00